Copyright
©The Author(s) 2023.
World J Diabetes. Nov 15, 2023; 14(11): 1621-1631
Published online Nov 15, 2023. doi: 10.4239/wjd.v14.i11.1621
Published online Nov 15, 2023. doi: 10.4239/wjd.v14.i11.1621
lncRNA | Description | Expression in obesity | Expression in DM |
SRA | Steroid receptor RNA activator | High | Low in patients with type II diabetic cardiovascular disease[74] |
ASMER-1 | Adipocyte-associated metabolic related lncRNA 1 | High in ScAT | High expression related to IR[20] |
ASMER-2 | Adipocyte-associated metabolic related lncRNA 2 | High in ScAT | High expression related to IR[20] |
ADNCR | Adipocyte differentiation-associated lncRNA | Low | Low[23] |
HOTAIR | HOX antisense intergenic RNA | High | High[71] |
Blnc1 | Brown fat lncRNA 1 | High in high-fat-diet-fed mice[28] | High in the blood of patients with diabetic nephropathy[82] |
H19 | LncRNA H19 | Low in obesity-associated inflammatory conditions[83] | Low[84] |
MALAT1 | Metastasis-associated lung adenocarcinoma transcript 1 | High[85] | High expression in PBMCs from type 2 diabetes patients[39] |
- Citation: Guo YC, Cao HD, Lian XF, Wu PX, Zhang F, Zhang H, Lu DH. Molecular mechanisms of noncoding RNA and epigenetic regulation in obesity with consequent diabetes mellitus development. World J Diabetes 2023; 14(11): 1621-1631
- URL: https://www.wjgnet.com/1948-9358/full/v14/i11/1621.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i11.1621